Nov 19, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Generate Biomedicines on a series of immunopeptidomics projects. On Nov 18 2021, Generate Biomedicines just announced a Series B financing of $370 million to advance its protein-targeted drug generation platform.
Nov 15, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Netherlands Cancer Institute on a series of quantitative phosphoproteomics projects.
Nov 10, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Patrick S. Moore and his team from University of Pittsburgh on a series of clinical proteomics projects focusing on leveraging our neoantigen quantification assays for biological discoveries.
Sept 16, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Dianqing (Dan) Wu from Yale University on a series of quantitative proteomics focusing on leveraging our clinical quantitative proteomics assays for biological discoveries.
Aug 30, 2021 | BALTIMORE – Complete Omics’ Clinical Genomics team announced a collaboration with Professor Ching-shuen Wang from Taipei Medical University on a series of RNA-seq projects leveraging our DEEPER-SeqS clinical genomics assays for biological discoveries from hard-to-sequence clinical samples.
July 18, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Yiping He from Duke University on a series of grants focusing on leveraging our labeling-dependent large scale quantitative proteomics assays for biological discoveries.
July 16th, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Prof. Dr. Roland Schüle from University Medical Center Freiburg, the teaching hospital of the University of Freiburg.
July 15, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Benjamin Vincent from The University of North Carolina, on neoantigen-related projects.
July 10, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Christian S. Hinrichs from Rutgers Cancer Institute of New Jersey.
June 25, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Arvinas (Nasdaq:ARVN), a pharmaceutical company inventing the famous proprietary PROTAC® protein degraders.
